Moxifloxacin NDC 67296-2129

NDC codes

FDA NDC Directory

Product NDC (as listed)67296-2129Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67296-2129Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67296-2129-3	67296212903	1 BOTTLE in 1 CARTON (67296-2129-3) / 3 mL in 1 BOTTLEMarketed from Jul 1, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Moxifloxacin
Generic name (nonproprietary): moxifloxacin
Active ingredients: Moxifloxacin hydrochloride monohydrate — 5 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Redpharm Drug
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202867
Marketing start: Jul 1, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Fluoroquinolones (Chemical structure)
Identifiers: Product ID 67296-2129_4698d4e7-2e86-6fbf-e063-6294a90a0d1eSPL ID 4698d4e7-2e86-6fbf-e063-6294a90a0d1eSPL set ID 301eef74-16db-14aa-e063-6294a90ac8ffRxCUI 403818UNII B8956S8609UPC 0368180422013
Pharmacologic class: Fluoroquinolone Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467296212903 followed by a unit qualifier and the quantity

Package 67296-2129-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 23, 2025.

Indications (excerpt from the label)

Moxifloxacin ophthalmic solution, 0.5% is a topical fluoroquinolone anti- infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species*, Micrococcus luteus*, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri*, Streptococcus pneumoniae, Streptococcus viridans group, Acinetobacter lwoffii*, Haemophilus influenzae, Haemophilus parainfluenzae*, Chlamydia trachomatis *Efficacy for this organism was studied in fewer than 10 infections. ( 1 ) Moxifloxacin ophthalmic solution, 0.5% is indicated for the treatment of bacterial conjunctiviti…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202867

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202867
Product	Strength	Form · route	Labeler	Product NDC
Moxifloxacin	Moxifloxacin hydrochloride 5 mg/mL	Solution/ dropsOphthalmic	A-S Medication Solutions	50090-6357
Moxifloxacin	Moxifloxacin hydrochloride monohydrate 5 mg/mL	Solution/ dropsOphthalmic	Direct Rx	72189-321
Moxifloxacin	Moxifloxacin hydrochloride monohydrate 5 mg/mL	Solution/ dropsOphthalmic	Advanced Rx Pharmacy of Tennessee, LLC	80425-0379
Moxifloxacin	Moxifloxacin hydrochloride monohydrate 5 mg/mL	Solution/ dropsOphthalmic	Lupin Pharmaceuticals, Inc.	68180-422